Carbamazepine
Therapeutic Category
- Anti-convulsant
Innovator Brand
GMP
DMF
Filed
Under Filing
Sample
Indication
Carbamazepine API with CAS# 298-46-4, is used to manage and treat epilepsy, trigeminal neuralgia, and acute manic and mixed episodes in bipolar I disorder. Indications for epilepsy are specifically for partial seizures with complex symptomatology (psychomotor, temporal lobe), generalized tonic seizures (grand mal), and mixed seizure patterns.
CTX Lifesciences, is one of the leading Active Pharmaceutical Ingredients (API) manufacturers and suppliers globally for Carbamazepine API with CAS# 298-46-4 . We are a leading exporter of Carbamazepine API with CAS# 298-46-4 from India. We are a trusted supplier with API exports in more than 87 Countries including the US, Europe, Brazil, Latin America, China, Korea,Iran, Middle East and other emerging markets.
CTX Lifesciences is one of the leading manufacturer & supplier of Carbamazepine API with CAS# 298-46-4 from India. This product is provided from our GMP compliant plant with product made under complete cGMP conditions. We provided with documentation support Drug Master File(DMF). Our manufacturing plant at Surat has accreditation by US-FDA, EDQM , EMA , ANVISA, KFDA, MOH IRAN, Health Canada & Russian Authorities.
Please also check other API products in the same segment as below.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.